Filter
1304
Text search:
Antimicrobial
resistance
Featured
Recommendations
153
New Publications
251
Language
Document type
Studies & Reports
323
No document type
323
Guidelines
280
Strategic & Response Plan
94
Manuals
80
Fact sheets
78
Online Courses
30
Resource Platforms
23
Training Material
22
Videos
15
Infographics
14
Situation Updates
12
Brochures
9
Dashboards/Maps
1
Countries / Regions
Global
60
India
42
South Africa
34
Kenya
31
Africa
30
Western and Central Europe
26
Ethiopia
24
Latin America and the Carribbean
22
Nigeria
16
Ghana
12
Uganda
12
Nepal
12
Sierra Leone
10
Tanzania
10
Malawi
9
Western Pacific Region
9
Liberia
8
Namibia
8
South–East Asia Region
8
Asia
8
Eastern Europe
8
Philippines
7
Bangladesh
7
Eastern Europe and Central Asia
7
Russia
7
Cameroon
6
Zimbabwe
6
Zambia
6
Rwanda
6
Indonesia
6
Ukraine
6
Myanmar / Burma
5
Burkina Faso
4
Senegal
4
Germany
4
Vietnam
4
Mali
3
Haiti
3
South Sudan
3
Thailand
3
China
3
Argentina
3
Eswatini/ Swaziland
3
Colombia
3
Lesotho
3
East and Southern Africa
3
West and Central Africa
3
Tajikistan
3
Congo, Democratic Republic of
2
Pakistan
2
Jordan
2
Syria
2
Cambodia
2
Mozambique
2
Peru
2
Brazil
2
North Macedonia
2
Serbia
2
Bolivia
2
Madagascar
2
Chile
2
Middle East and North Africa
2
Laos
2
Georgia
2
Gabon
2
Uruguay
2
France
2
Guinea
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Saudi Arabia
1
Niger
1
Somalia
1
Iraq
1
Afghanistan
1
Lebanon
1
Egypt
1
Sudan
1
Benin
1
Honduras
1
El Salvador
1
Libya
1
Angola
1
Guatemala
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Yemen
1
Paraguay
1
Fiji
1
Bhutan
1
Venezuela
1
Armenia
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
306
Clinical Guidelines
95
Key Resources
86
Public Health
48
Women & Child Health
37
Pharmacy & Technologies
20
Capacity Building
16
Annual Report MEDBOX
3
Toolboxes
AMR
553
TB
80
Planetary Health
80
COVID-19
58
HIV
57
Pharmacy
48
Caregiver
45
Global Health Education
34
Rapid Response
33
NTDs
32
2.0 Rapid Response
30
Health Financing Toolbox
22
Cholera
18
Ebola & Marburg
16
Refugee
16
Malaria
14
Mental Health
10
Conflict
8
NCDs
6
Natural Hazards
4
Polio
3
Disability
1
Zika
1
The purpose of this document is to present and promote the minimum requirements for IPC programmes at the national and health care facility level, identified by expert consensus according to available evidence and in the context of the WHO core components.
The minimum requirements are defined as: I
...
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate
...
World Journal of Pharmaceutical and Medical Research vol. 5 (2019) 3, 129-132
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w
...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot
...
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover
...
This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and the Government of South Africa. It sets out the working group’s shared vision for equitable access to novel TB vaccines and will advance a shared understanding of the current lands
...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
The majority of developing countries will fail to achieve their targets for Universal Health Coverage (UHC)1 and the health- and poverty-related Sustainable Development Goals (SDGs) unless they take urgent steps to strengthen their health financing. Just over a decade out from the SDG deadline of 20
...
Cholera is an acute diarrhoeal disease caused by the ingestion of food or water contaminated with the bacterium V.
cholerae. It has a short incubation period of a few hours to 5 days. It is endemic in some countries, frequently
showing seasonal variations in the number of reported cases. Cholera a
...
Review Article:
The American Journal of the Medical Sciences 2011;341(6):493–498.]
Accessed Febr. 6, 2020
During the year 2022, COVID-19 continued to be a significant challenge in Eritrea as in many other countries across the world. As COVID-19 devastated communities around the world, WHO worked with the MoH to strengthen the National and Sub-National health systems in order to meet community needs and
...
